BIOGEN INC.: accounts_receivable
| Value | {"amount": 1292400000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2014-12-31) |
| Status | current |
| Entity | BIOGEN INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:41:57.954245+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a2f42303-2865-4da3-a6c2-864d78615789
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000875045-16-000042Retrieved: 2026-08-19T08:41:57.954245+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875045/accounts-receivable/2014-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a2f42303-2865-4da3-a6c2-864d78615789
History
- supersedes {"amount": 1292445000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} (evidence 0000875045-15-000005)